Last updated: May 30, 2026
This article is educational and is not a substitute for diagnosis or treatment from a licensed oncologist. Cancer care changes quickly, and international treatment decisions should be based on your actual pathology, imaging, biomarkers, health status, and treatment goals.
Quick Answer
For prostate cancer in Germany, the first issue is risk group, not country. Low-risk disease may not need immediate treatment; intermediate- and high-risk disease require careful comparison of surgery, external-beam radiation, brachytherapy, hormone therapy, and sometimes systemic treatment. Proton therapy should be evaluated against modern photon radiation, not assumed superior.
Related guides in this oncology cluster: Proton Therapy in Germany for International Patients, USA vs Germany Cancer Treatment, Cancer Treatment in Germany for Foreign Patients.
Who This Guide Is For
Patients with newly diagnosed localized prostate cancer, recurrent disease, or metastatic prostate cancer comparing treatment approaches.
The practical search intent behind “prostate cancer treatment Germany surgery radiation proton” is usually not just curiosity. Patients want to know whether the option is medically appropriate, how to avoid paying for the wrong care, what records are needed, and how to compare the recommendation with local treatment.
Key Takeaways
- A useful German second opinion should define risk group using PSA, Gleason/Grade Group, MRI, biopsy cores, stage, and imaging.
- Treatment choice affects urinary, sexual, bowel, and hormonal side effects differently.
- Robotic surgery, radiation, proton therapy, and hormone therapy should be compared with the patient’s life expectancy and priorities.
- For metastatic prostate cancer, systemic therapy access and sequencing become more important than local procedure choice.
Decision Map
| Decision | Why it matters | What to ask |
|---|---|---|
| Risk group | Low-, intermediate-, high-, and very high-risk prostate cancer are managed differently. | Which risk group am I in and why? |
| Local treatment | Surgery and radiation have different side-effect profiles. | What are my expected urinary, sexual, and bowel risks? |
| Imaging | MRI and modern staging can change treatment fields. | Do I need repeat MRI, PSMA PET, or staging scans before treatment? |
| Proton value | Proton therapy is not automatically superior for prostate cancer. | What normal-tissue advantage does the proton plan show for me? |
How to Evaluate This Option
Prostate cancer searches often jump to hospitals that advertise robotic surgery or proton therapy. A better starting point is the disease risk group. PSA, biopsy Grade Group, number of positive cores, MRI findings, extracapsular extension, seminal vesicle involvement, lymph-node suspicion, and metastasis status all affect treatment.
For low-risk disease, active surveillance may be appropriate. For favorable intermediate-risk disease, surgery or radiation may both be reasonable. For high-risk disease, treatment often combines local therapy with hormone therapy and sometimes broader staging or systemic options.
Germany can be useful for a second opinion when the patient has conflicting recommendations, wants to understand nerve-sparing surgery feasibility, is considering radiation after prostatectomy, or is asking whether proton therapy adds enough value to justify travel and cost.
Cost questions should include not only the initial procedure but also catheter care, pathology, radiation fractions, hormone injections, follow-up PSA tests, salvage treatment risk, and management of side effects.
Cost and Timeline Questions
- For surgery, ask whether robotic system fees, anesthesia, hospital stay, pathology, complications, and catheter removal are included.
- For radiation, ask about simulation, planning, number of fractions, image guidance, fiducials or spacer, and hormone therapy.
- For proton therapy comparison, read proton therapy in Germany.
- For USA comparison, see proton therapy in the USA.
Medical Records Checklist
- Pathology report, immunohistochemistry report, and information on where the tissue block or slides are stored.
- Imaging reports and DICOM files for CT, MRI, PET/CT, bone scan, mammography, ultrasound, or nuclear medicine studies.
- Operation reports, radiation summaries, discharge summaries, and any complications that changed the treatment plan.
- Systemic therapy history: drug names, dates, doses, dose reductions, response, progression dates, and serious side effects.
- Biomarker, molecular, genomic, cytogenetic, and germline genetic reports, even if a later hospital plans to repeat testing.
Questions to Ask the Oncologist
- What diagnosis, stage, grade, and molecular subtype are you using to make the recommendation?
- What parts of the plan are standard of care, and what parts are optional, experimental, or available only in a trial?
- What result would change the plan: new pathology, a biomarker result, a new scan, or a multidisciplinary tumor board review?
- How quickly does treatment need to start, and is travel medically safe during that waiting period?
- What costs are included in the written estimate, and what costs could be billed separately?
Red Flags Before You Pay
- A clinic promises a cure before reviewing pathology, staging scans, and prior treatment history.
- The provider asks for full payment before giving a named physician, treatment plan, and written cost estimate.
- The recommendation ignores biomarker testing for a cancer where biomarkers commonly guide treatment.
- The clinic discourages you from discussing the plan with your current oncologist.
- A paid treatment is described as a clinical trial but is not listed in a recognized registry or ethics-approved protocol.
Internal Reading Path
- Proton Therapy in Germany for International Patients
- USA vs Germany Cancer Treatment
- Cancer Treatment in Germany for Foreign Patients
- Online Cancer Second Opinion in Germany